Indications and uses
helps prevent sunburn If used as directed with other sun protection measures (see Directions ), decreases the risk of skin cancer and early skin aging caused by the sun
Obagi-C C-Rx System Normal-Dry Skin Intervention
- Manufacturer
- Obagi Cosmeceuticals LLC | Bay Cities Container Corporation | G. S. Cosmeceutical USA, Inc. | Swiss American CDMO, LLC | Universal Packaging Systems, Inc. (DBA Paklab) | PURETEK CORPORATION
- Effective date
- 2025-11-13
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 3
- Source
- full-release
- Hydrated at
- 2026-06-01 01:16:17
Label at a glance#
ProductObagi-C C-Rx System Normal-Dry Skin Intervention
Active ingredientHYDROQUINONE, TITANIUM DIOXIDE, ZINC OXIDE
Label structure10 sections
Dosage and administration
apply liberally 15 minutes before sun exposure use a water resistant sunscreen if swimming or sweating reapply at least every 2 hours Sun Protection Measures. Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a Broad Spectrum SPF value of 15 or higher and other sun protection measures including: limit time in the sun, especially ...
Storage and handling
store at controlled room temperature: 15°C–25°C (59°F–77°F) protect this product from excessive heat and direct sun
Contacts and useful links#
Label contents#
Full prescribing information#
SPL UNCLASSIFIED SECTION
Drug Facts
OTC - ACTIVE INGREDIENT SECTION
OTC - PURPOSE SECTION
| Active ingredients | Purpose |
|---|---|
| Titanium Dioxide 6.2% | Sunscreen |
| Zinc Oxide 15.6% | Sunscreen |
Uses
- helps prevent sunburn
- If used as directed with other sun protection measures (see Directions), decreases the risk of skin cancer and early skin aging caused by the sun
Warnings
For external use only
OTC - DO NOT USE SECTION
Do not use on damaged or broken skin
OTC - STOP USE SECTION
Stop use and ask a doctor if rash occurs
OTC - WHEN USING SECTION
When using this product keep out of eyes. Rinse with water to remove.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.
Directions
- apply liberally 15 minutes before sun exposure
- use a water resistant sunscreen if swimming or sweating
- reapply at least every 2 hours
- Sun Protection Measures. Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a Broad Spectrum SPF value of 15 or higher and other sun protection measures including:
- limit time in the sun, especially from 10 a.m.–2 p.m.
- wear long-sleeved shirts, pants, hats, and sunglasses
- children under 6 months: Ask a doctor
Other information
- store at controlled room temperature: 15°C–25°C (59°F–77°F)
- protect this product from excessive heat and direct sun
Inactive ingredients
aqua/water/eau, caprylic/capric triglyceride, dicaprylyl carbonate, pentylene glycol, steareth-2, glycerin, silica, polyhydroxystearic acid, steareth-21, cetearyl alcohol, propanediol, alumina, stearic acid, sodium stearoyl glutamate, caprylyl glycol, triethoxycaprylylsilane, cetearyl glucoslde, xanthan gum, dipotassium glycyrrhizate,trisodium ethylenediamine disuccinate, caprylhydroxamic acid, tropaeolum majus flower/leaf/stem extract.
Questions or comments?
1.800.636.7546 Monday–Friday 9 a.m.–4 p.m. PST
SPL UNCLASSIFIED SECTION
Distributed by Obagi Cosmeceuticals LLC,
Long Beach, CA 90806.
PRINCIPAL DISPLAY PANEL - Kit Carton
OBAGI®
MEDICAL
OBAGI-C® Rx SYSTEM
Complete skin care system specifically formulated for normal to dry skin with
hydroquinone to reduce hyperpigmentation and other essential ingredients to help
address the signs of sun exposure caused by photoaging.
NORMAL DRY
Skin Intervention Kit
DailyMed RxNorm Mappings#
DailyMed Pharmacologic Classes#
| Class | Version | Type | Effective |
|---|---|---|---|
| HYDROQUINONE Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 0ca1d589-929b-4b33-bc5b-1d84abdafa6a | Product name | 1 | 20150324 |
| fc363c46-397b-4476-ac0f-70e43e8e4592 | Product name | 1 | 20150324 |
| 1681bc73-b05f-12c3-1075-382ae39f449c | Product name | 1 | 20140508 |
| 85490a6b-2306-6bf2-c51b-eb63537dc2da | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 62032-105-36 | Obagi-C C-Rx System Normal-Dry Skin Intervention | 57 g in 1 BOTTLE, PLASTIC | CREAM | 57 g | 40 mg in 1g | 3 |
| 62032-106-10 | Obagi-C C-Rx System Normal-Dry Skin Intervention | 30 mL in 1 BOTTLE, GLASS | SOLUTION | 30 mL | 40 mg in 1mL | 3 |
| 62032-106-10 | Obagi-C C-Rx System Normal-Dry Skin Intervention | 1 in 1 CARTON | SOLUTION | 40 mg in 1mL | 3 | |
| 62032-811-09 | Obagi-C C-Rx System Normal-Dry Skin Intervention | 85 g in 1 TUBE | LOTION | 85 g | 15.6 g in 100g | 3 |
| 62032-811-09 | Obagi-C C-Rx System Normal-Dry Skin Intervention | 1 in 1 CARTON | LOTION | 6.2 g in 100g | 3 | |
| 62032-922-01 | Obagi-C C-Rx System Normal-Dry Skin Intervention | 1 in 1 BAG | KIT | 1 | 3 |
Products#
Every source-derived product name is available through these pages.
- Obagi-C C-Rx System Normal-Dry Skin Intervention
- HYDROQUINONE, TITANIUM DIOXIDE, ZINC OXIDE
- OBAGI C RX System C CLARIFYING SERUM
- HYDROQUINONE
- PROPYLENE GLYCOL
- WATER
- ASCORBIC ACID
- SODIUM LAURYL SULFATE
- PROPYLENE CARBONATE
- OBAGI-C RX System C-THERAPY NIGHT Skin Lightening with Vitamins C and E
- EDETATE DISODIUM
- PPG-2 MYRISTYL ETHER PROPIONATE
- TROLAMINE SALICYLATE
- CETYL ALCOHOL
- LACTIC ACID, UNSPECIFIED FORM
- .ALPHA.-TOCOPHEROL ACETATE
- SODIUM METABISULFITE
- METHYLPARABEN
- PROPYLPARABEN
- BUTYLATED HYDROXYTOLUENE
- PHENYL TRIMETHICONE
- GLYCERIN
- SUN SHIELD MINERAL BROAD SPECTRUM SPF 50 SUNSCREEN
- titanium dioxide and zinc oxide
- TITANIUM DIOXIDE
- ZINC OXIDE
- ALUMINUM OXIDE
- CAPRYLHYDROXAMIC ACID
- MEDIUM-CHAIN TRIGLYCERIDES
- CAPRYLYL GLYCOL
- CETOSTEARYL ALCOHOL
- DICAPRYLYL CARBONATE
- GLYCYRRHIZINATE DIPOTASSIUM
- PENTYLENE GLYCOL
- POLYHYDROXYSTEARIC ACID (2300 MW)
- PROPANEDIOL
- SILICON DIOXIDE
- SODIUM STEAROYL GLUTAMATE
- STEARETH-2
- STEARETH-21
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 62032-922 | 62032-922-01 |
| 62032-106 | 62032-106-10 |
| 62032-105 | 62032-105-36 |
| 62032-811 | 62032-811-09 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.